SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease

NCT00725478 · clinicaltrials.gov ↗

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Piribedil

Sponsor

Desitin Arzneimittel GmbH